it shows that the longest waits for cancer treatment have soared since 2010.
.
.in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.
.
.
harvard medical school: "cgrp: a new era for migraine treatment."
.
.
.